364
Participants
Start Date
July 1, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Dexmedetomidine
Dexmedetomidine Hydrochloride Nasal Spray Dexmedetomidine is a selective alpha-2 adrenergic agonist primarily used for its sedative, anxiolytic, and analgesic effects. It works by inhibiting the release of norepinephrine in the central nervous system, leading to sedation, decreased anxiety, and reduced pain sensitivity. When used intranasally, it can offer an effective, non-invasive method for sedating patients and improving sleep quality, particularly in perioperative settings.
Saline solution
The saline solution will be used as a placebo, and the same device will be employed for intranasal administration.
Department of Anesthesiology, Peking Union Medical College Hospital, Beijing
National Cancer Center/National Cancer Clinical Medical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
UNKNOWN
Peking Union Medical College Hospital
OTHER